Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)Ying‐Hsia Chu, Peter M. Sadow, William C. Faquin et al.|Modern Pathology|2020Cited by 103
TRK inhibitor in a patient with metastatic triple-negative breast cancer and <i>NTRK</i> fusions identified <i>via</i> cell-free DNA analysisArielle J. Medford, Aditya Bardia, Rachel O. Abelman et al.|Therapeutic Advances in Medical Oncology|2023Cited by 11